Cat scratch disease (CSD) neuroretinitis is the most common infectious cause of neuroretinitis, caused by Bartonella henselae. It presents with optic disc edema and a macular star (stellate exudates) and is typically unilateral and self-limited, though antibiotic treatment is recommended for sight-threatening disease. [1-3]
1. History
- Key HPI questions: Acute or subacute unilateral vision loss, blurred vision, central scotoma, headache, mild periorbital pain [2-3]
- Symptom characterization: Painless or mildly painful visual loss developing over days; dyschromatopsia (color vision changes); floaters [2][4]
- Timing: Ocular symptoms typically develop 2–8 weeks after initial inoculation (scratch/bite); macular star may not appear until 1–2 weeks after disc edema onset [5-6]
- Triggers: History of cat scratch, bite, or lick on broken skin; kitten exposure is highest risk; flea exposure [6-7]
- Associated symptoms: Preceding fever, malaise, lymphadenopathy (may have resolved by time of ocular presentation) [4][8]
- Important negatives: Ask about absence of pain with eye movement (helps distinguish from demyelinating optic neuritis), no neurologic symptoms, no rash [8]
2. Alarm Features
- Bilateral involvement or severe vision loss (worse than 20/200) [9]
- Encephalopathy or seizures — CSD encephalitis occurs in ~0.5% of cases; seizures in 68% of those, including status epilepticus [10]
- Hepatosplenic involvement (abdominal pain, hepatomegaly) — disseminated CSD in ~2% of cases [6][11]
- Immunocompromised state (HIV/AIDS) — risk of bacillary angiomatosis, peliosis hepatis, bacteremia [12]
- Endocarditis — culture-negative endocarditis in patients with prolonged fever and new murmur [13]
- Vitritis, pre-retinal hemorrhage, retinal artery occlusion — suggest severe ocular bartonellosis requiring aggressive treatment [14-15]
3. Medications
- First-line for neuroretinitis: Oral doxycycline 100 mg BID ± rifampin 300 mg BID for 4–6 weeks [4]
- Alternative: Azithromycin 500 mg day 1, then 250 mg daily × 4 days (IDSA-recommended for uncomplicated CSD lymphadenopathy; less data for neuroretinitis) [6]
- Corticosteroids: Combined antibiotics + oral prednisone associated with significantly better visual outcomes (OR 7.0 for ≥3-line improvement vs antibiotics alone). Oral prednisone recommended during initial inflammatory phase [9][14]
- Caution with rifampin: Rifampin is a potent CYP inducer — reduces plasma levels of prednisone and doxycycline; avoid combining all three simultaneously [12][14]
- In pregnancy: Erythromycin or alternative macrolide preferred over doxycycline [12]
- Contraindicated: Doxycycline in children <8 years (relative; short courses may be acceptable); first/second-generation cephalosporins lack efficacy against Bartonella [12]
4. Diet
- No specific dietary triggers or restrictions
- Ensure adequate hydration, particularly if febrile
- If on doxycycline, avoid dairy products and antacids within 2 hours of dosing (chelation reduces absorption)
5. Review of Systems
- Constitutional: Fever, malaise, weight loss, fatigue [4][16]
- HEENT: Visual acuity changes, color vision changes, eye pain, photophobia, floaters
- Lymphatic: Regional lymphadenopathy (cervical, axillary, inguinal — draining the inoculation site) [6]
- GI: Abdominal pain (hepatosplenic involvement) [11]
- Neurologic: Headache, confusion, seizures (encephalitis) [10]
- Skin: Papule or pustule at inoculation site (may have resolved) [6]
- MSK: Bone pain (rare osteomyelitis) [17]
6. Collateral History and Family History
- Cat/kitten exposure is the single most important collateral detail — present in ~90% of cases [7][18]
- Age and health of the cat (kittens <1 year are more likely bacteremic)
- Flea infestation in the household
- Immunocompromised household contacts (risk of bacillary angiomatosis)
- Family history is not directly relevant (CSD is not hereditary), but household members with similar cat exposure may also be at risk
7. Risk Factors
- Cat ownership, especially kittens <12 months old [7][19]
- Cat scratches, bites, or licks on broken skin [6]
- Flea exposure (cat fleas transmit B. henselae between cats) [7]
- Children and young adults — peak incidence ages 5–14 years [17][20]
- Southern US states, peak incidence in autumn/winter (January peak) [20]
- Immunosuppression (HIV/AIDS, biologics, transplant) — risk of disseminated/severe disease [12-13]
8. Differential Diagnosis
- Demyelinating optic neuritis (MS-associated): Pain with eye movement, no macular star, associated with MS risk; neuroretinitis is NOT associated with MS [3][8]
- Syphilitic neuroretinitis: Must be excluded; RPR/VDRL + FTA-ABS [3][5]
- Lyme disease: Optic neuritis/neuroretinitis in endemic areas; Lyme serology [4]
- Toxoplasmosis: Focal retinochoroiditis with overlying vitritis; toxoplasma IgG/IgM [4]
- Sarcoidosis: Granulomatous uveitis, optic disc edema; ACE level, chest imaging [3][5]
- Idiopathic/recurrent neuroretinitis: Diagnosis of exclusion; recurrent episodes suggest poorer visual prognosis [2]
- Anterior ischemic optic neuropathy (AION): Older patients, altitudinal field defect, no macular star
- Papilledema (raised ICP): Bilateral disc edema, no macular star initially, headache with positional features
- Idiopathic intracranial hypertension: Can be confused with neuroretinitis, especially in young women [21]
9. Past Medical History
- Prior episodes of neuroretinitis (recurrent neuroretinitis carries worse prognosis) [2]
- HIV/AIDS status or other immunosuppression [12]
- History of autoimmune/inflammatory disease (sarcoidosis, MS)
- Prior ocular surgery or trauma
- History of STIs (syphilis must be excluded)
10. Physical Exam
- Visual acuity: Ranges from 20/40 to counting fingers at presentation [4][9]
- Color vision testing: Dyschromatopsia (impaired color vision in affected eye) [2][4]
- Pupillary exam: Relative afferent pupillary defect (RAPD) in the affected eye [3-4]
- Fundoscopy (key findings):
- Optic disc edema (swollen, hyperemic disc) [1]
- Macular star — stellate hard exudates radiating from the fovea (may be delayed 1–2 weeks after disc edema) [5]
- Nerve fiber layer hemorrhages, cotton-wool spots [4]
- Peripapillary exudates
- Possible focal retinal/choroidal white lesions [15]
- Visual field testing: Central or cecocentral scotoma [2]
- Lymph node exam: Regional lymphadenopathy draining the inoculation site
- Skin exam: Look for inoculation papule/pustule (may have healed)
- Vital signs: Low-grade fever may be present
11. Lab Studies
- B. henselae serology (IFA): IgM and IgG antibodies — IgG ≥1:256 is suggestive; ≥1:512 is more specific; 4-fold rise in convalescent titers confirms diagnosis [22-23]
- Antibodies may not be detectable for up to 6 weeks after acute infection [12]
- Sensitivity ~64% for neuroretinitis patients [22]
- PCR for B. henselae DNA: Can be performed on blood, lymph node tissue, or aqueous humor; most sensitive in first week of illness [12][24]
- Rule-out labs:
- RPR/VDRL + FTA-ABS (syphilis) [4]
- Lyme serology (endemic areas)
- Toxoplasma IgG/IgM
- ACE level (sarcoidosis)
- QuantiFERON/PPD (tuberculosis)
- CBC, ESR, CRP — ESR/CRP elevation is atypical for demyelinating optic neuritis and should raise suspicion for infectious etiology [8]
- Blood cultures: Low yield due to fastidious organism; EDTA tubes, prolonged incubation on chocolate agar [12]
12. Imaging
- Fundus photography/OCT: Document disc edema, macular star, retinal lesions; useful for monitoring resolution
- Fluorescein angiography: Disc leakage, peripapillary capillary dilation; helps characterize retinal vascular involvement [15]
- MRI brain and orbits with contrast: May show optic nerve enhancement; primarily used to exclude demyelinating disease, compressive lesions, or other CNS pathology [3]
- Abdominal imaging (CT/US): If hepatosplenic involvement suspected (fever, abdominal pain) — look for microabscesses [11]
- Imaging is unnecessary in straightforward cases with classic presentation and positive serology
13. Special Tests
- Visual field testing (Humphrey): Central or cecocentral scotoma [2]
- OCT (optical coherence tomography): Quantifies disc edema, subretinal fluid, macular exudates
- Electrophysiology (if needed): VEP may be abnormal; ERG typically normal [4]
- Warthin-Starry silver stain: On lymph node biopsy tissue — demonstrates bacilli but cannot speciate [6]
- mNGS (metagenomic next-generation sequencing): Emerging diagnostic tool, especially when conventional tests are inconclusive [25-26]
14. ECG
- Not routinely indicated for isolated neuroretinitis
- Obtain ECG/echocardiogram if:
- Prolonged fever of unknown origin
- New cardiac murmur
- Suspicion for Bartonella endocarditis (culture-negative endocarditis) — IgG ≥1:800 is a major Duke criterion [12]
15. Assessment
Cat scratch disease neuroretinitis is a clinical entity defined by optic disc edema with a macular star pattern caused by B. henselae infection. It is the most common infectious cause of neuroretinitis, accounting for ~64% of cases in one series. [22] The optic disc is the primary target, with secondary leakage of lipid-rich exudates into the macula forming the characteristic star. [1][5]
- Typical presentation: Young patient with subacute unilateral vision loss, history of cat exposure, disc edema ± macular star, and positive Bartonella serology [3]
- Atypical presentations: Bilateral involvement (~5%), absence of lymphadenopathy or fever at time of ocular presentation, no recalled cat exposure [8]
- Severity stratification: 33% present with good VA (>20/40), 44% with moderate loss (20/40–20/200), 23% with severe loss (<20/200) [9]
- Complications: Residual disc pallor, persistent RAPD, retinal pigmentary changes, mild postinfectious optic neuropathy in some patients; vitritis, pre-retinal hemorrhage, branch retinal artery occlusion in severe cases [4][15]
16. Treatment Plan
Initial management
- Doxycycline 100 mg PO BID × 4–6 weeks — mainstay for neuroretinitis [4][8]
- Consider adding oral prednisone (e.g., 1 mg/kg/day with taper over 2–4 weeks) for significant vision loss — combined antibiotics + corticosteroids showed significantly better visual outcomes [9][14]
- Avoid rifampin if using concurrent prednisone or doxycycline due to drug interactions reducing their levels [14]
- If rifampin is used (e.g., doxycycline 100 mg BID + rifampin 300 mg BID), do not co-administer with systemic steroids [4]
For CNS involvement: Doxycycline 100 mg PO/IV BID ± rifampin 300 mg BID [12]
For immunocompromised patients: Treat for at least 3 months; consider long-term suppressive therapy if CD4 <200 [12]
Adjunctive topical therapy: Topical ketorolac 0.5% BID and difluprednate 0.05% QID have been reported as beneficial adjuncts in severe cases [14]
Mild/self-limited cases: Visual recovery often occurs spontaneously without treatment, but most experts favor early antibiotic therapy to limit progression and ensure organism eradication [2][7]
17. Disposition
- Outpatient management is appropriate for most cases of isolated neuroretinitis with stable vision
- Admission criteria:
- Severe bilateral vision loss
- Encephalitis/encephalopathy or seizures [10]
- Disseminated disease (hepatosplenic, endocarditis) [17]
- Need for IV antibiotics or IV methylprednisolone
- Immunocompromised with systemic decompensation [12]
- Ophthalmology consultation: Urgent referral for all cases of suspected neuroretinitis for dilated fundoscopic exam, OCT, and visual field testing
- Infectious disease consultation: For atypical, disseminated, or immunocompromised cases
18. Follow Up / Return Precautions
- Ophthalmology follow-up within 1–2 weeks to assess for macular star development (may not be present initially) and monitor visual acuity [5]
- Repeat visual acuity and fundoscopy at 4–6 weeks to confirm resolution
- Convalescent serology at 2–4 weeks if initial titers were low or negative [23]
- Expected recovery: Most patients (80%) achieve final VA better than 20/40; macular star may take weeks to months to fully resolve [9]
- Return precautions — instruct patients to return immediately for:
- Worsening or new vision loss in either eye
- New-onset headache, confusion, or seizures
- High fever, abdominal pain
- Symptoms in the contralateral eye
- Long-term: Some patients may have residual mild optic neuropathy with subtle color vision or contrast sensitivity deficits [4]
- Prevention counseling: Flea control for cats, avoid rough play with kittens, wash cat scratches/bites promptly [7][19]
References
1. Neuroretinitis: A Comprehensive Review on Aetiologies, Clinical Manifestations, and Treatment Options. — Shi J, Danesh-Meyer HV, Bhatti MT. Eye. 2025.
2. Neuroretinitis: A Review. — Abdelhakim A, Rasool N. Current Opinion in Ophthalmology. 2018.
3. Diagnosis and Clinical Features of Common Optic Neuropathies. — Biousse V, Newman NJ. The Lancet. Neurology. 2016.
4. Bartonella Henselae Neuroretinitis in Cat Scratch Disease. Diagnosis, Management, and Sequelae. — Reed JB, Scales DK, Wong MT, et al. Ophthalmology. 1998.
5. Optic Disk Edema With a Macular Star. — Brazis PW, Lee AG. Mayo Clinic Proceedings. 1996.
6. Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. — Stevens DL, Bisno AL, Chambers HF, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2014.
7. Ocular Bartonellosis. — Cunningham ET, Koehler JE. American Journal of Ophthalmology. 2000.
8. Suspecting Optic Neuritis, Diagnosing Bartonella Cat Scratch Disease. — Gan JJ, Mandell AM, Otis JA, Holmuhamedova M, Perloff MD. Archives of Neurology. 2011.
9. Cat-Scratch Disease: Ocular Manifestations and Treatment Outcome. — Habot-Wilner Z, Trivizki O, Goldstein M, et al. Acta Ophthalmologica. 2018.
10. Cat Scratch Disease Encephalitis: New Insights Into Rate, Clinical Features, and Long-Term Outcomes. — Yakubovsky M, Kadar L, Katchman E, et al. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases. 2026.
11. Cat-Scratch Disease in the Pediatric Population: 6 Years of Evaluation and Follow-Up in a Public Hospital in Chile. — Sandoval AC, Reyes FT, Prado MA, Peña AL, Viviani TN. The Pediatric Infectious Disease Journal. 2020.
12. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV. — Constance Benson, John Brooks, Shireesha Dhanireddy, et al Infectious Diseases Society of America; Office of AIDS Research Advisory Council (2025). 2025.
13. Disseminated Cat-Scratch Disease During Abatacept Therapy for Rheumatoid Arthritis in an Older Patient: A Case Report and Review of the Literature. — Saito H, Takahashi Y, Tsuge S, et al. Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy. 2025.
14. Case Report: Treatment of Severe Neuroretinitis and Other Sequelae Associated With Cat Scratch Disease. — Whorff J. Optometry and Vision Science : Official Publication of the American Academy of Optometry. 2022.
15. Retinal and Choroidal Manifestations of Cat-Scratch Disease. — Ormerod LD, Skolnick KA, Menosky MM, Pavan PR, Pon DM. Ophthalmology. 1998.
16. Cat Scratch Disease in a 23-Year-Old Male-Case Report. — Waseem R, Seher M, Ghazal S, Shah HH, Habiba U. Frontiers in Public Health. 2023.
17. Atypical Manifestations of Cat-Scratch Disease, United States, 2005-2014. — Nawrocki CC, Max RJ, Marzec NS, Nelson CA. Emerging Infectious Diseases. 2020.
18. A Retrospective Analysis of Systemic Bartonella Henselae Infection in Children. — Stroescu RF, Chisavu F, Steflea RM, et al. Microorganisms. 2024.
19. Cat-Scratch Disease. — Klotz SA, Ianas V, Elliott SP. American Family Physician. 2011.
20. Ophthalmic Manifestations of Bartonella Infection. — Amer R, Tugal-Tutkun I. Current Opinion in Ophthalmology. 2017.
21. Acute Unilateral Vision Loss in a Female Adolescent Due to Ocular Bartonellosis. — Nassif DS. Pediatric Emergency Care. 2019.
22. Prevalence of Serologic Evidence of Cat Scratch Disease in Patients With Neuroretinitis. — Suhler EB, Lauer AK, Rosenbaum JT. Ophthalmology. 2000.
23. Pediatric Bartonella Henselae Infection: The Role of Serologic Diagnosis and a Proposed Clinical Approach for Suspected Acute Disease in the Immunocompetent Child. — Alattas NH, Patel SN, Richardson SE, Akseer N, Morris SK. The Pediatric Infectious Disease Journal. 2020.
24. Serological and Molecular Detection of Bartonella Henselae in Specimens From Patients With Suspected Cat Scratch Disease in Italy: A Comparative Study. — Allizond V, Costa C, Sidoti F, et al. PloS One. 2019.
25. Clinical and Epidemiological Characteristics of Cat Scratch Disease in Children From Southwestern China: A Retrospective Analysis of mNGS-confirmed Cases. — Lai SY, Chang L, Duan JX, et al. Frontiers in Public Health. 2025.
26. A Case Report of Diagnosis of Cat-Scratch Disease Using Metagenomic Next-Generation Sequencing. — Zhou T, Zheng Y, Zhang H, Liu Y. Frontiers in Cellular and Infection Microbiology. 2023.